-
SYNGAP1-related intellectual disability with ataxia and late onset of epileptic seizures
-
Tardive Dystonia Successfully treated with DBS
-
Targeting the Receptor of Glial Cell Line-Derived Neurotrophic factor to treat Parkinson’s Disease
-
Task based profiles of language impairment in Parkinson’s Disease
-
Tau Neuropathology Associates with In Vivo Patterns of Neurodegeneration in Lewy Body Disorders
-
TAU pathology contributes to specific patterns of structural brain damage and neuropsychological heterogeneity in Huntington’s disease
-
Technology-based therapy response and prognostic biomarkers in Parkinson’s disease: results from a prospective evaluation of a de novo PD patients’ cohort
-
Temporal characterization of motor, gastrointestinal, and behavioral symptoms in a SNCA A53T transgenic mouse model of Parkinson’s disease
-
Temporal properties of resting-state functional MRI are associated with ON/OFF levodopa MDS-UPDRS III scores in patients with Parkinson’s disease
-
Temporhythmal Correction: The New Way of Therapy and Diagnostic Secondary Vascular Parkinsonism
- « Previous Page
- 1
- …
- 127
- 128
- 129
- 130
- 131
- …
- 149
- Next Page »